Wright Medical Sales Gain On Strength Of Biologic, Extremity Implants In Q1
This article was originally published in The Gray Sheet
Executive Summary
Accelerating sales growth in Wright Medical's biologic implant franchise and a robust performance by the orthopedic firm's extremity products contributed to corporate revenue growth of 9% to $94.3 million in the first quarter, the firm reported April 30